Tilray Brands Inc vs Vanguard Total World Stock Index Fund ETF — how do they compare? Tilray Brands Inc trades at $3.54 (market cap $530.54M), while Vanguard Total World Stock Index Fund ETF trades at $159.83 (market cap $101.70B). The key difference: Vanguard Total World Stock Index Fund ETF is far larger — about 191.7× Tilray Brands Inc's market cap, and Vanguard Total World Stock Index Fund ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and Vanguard Total World Stock Index Fund ETF for 53 Days on average.
| TLRY | VT | |
|---|---|---|
Market Cap | $530.54M | $101.70B |
Volume | 9,099,075 | 1,783,794 |
Sector | Health | Broad Market / Factor |
52-Week High | $21.00 | $162.39 |
52-Week Low | $3.57 | $134.19 |
Typical Hold Time | 31 Days | 53 Days |
Enterprise Value | $684.46M | — |
Signals from Pluang's Aura AI — not financial advice
Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.
TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.
VT trades at $158.73, down 0.57% on the day, with technical indicators showing a bearish bias as moving averages signal selling pressure. The ETF maintains its position as a comprehensive global equity vehicle with over 9,700 holdings and a 0.06% expense ratio. Recent news highlights VT's diversification benefits and cost competitiveness against peers like Schwab International Equity ETF and iShares MSCI World ETF.
The outlook remains favorable for long-term investors seeking broad global exposure, though near-term technical weakness suggests potential testing of support levels. Key risks include global market volatility and currency fluctuations, while institutional activity shows mixed positioning with recent sales by Barry Investment Advisors offset by new stakes from FAS Wealth Partners.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →VT is a foundational, low-cost ETF that seeks to track the FTSE Global All Cap Index, providing exposure to nearly 10,000 stocks across developed and emerging markets worldwide, including the United States. It serves as a single-ticker solution for total global equity diversification, capturing approximately 98% of the world's investable market capitalization.
Read more on VT →